Safety of fruquintinib monotherapy and combination therapy in Chinese patients with colorectal cancer in real-world clinical practice: A subgroup analysis from phase IV study.

Authors
Category Primary study
Conference2025 ASCO Annual Meeting
Year 2025
This article has no abstract
Epistemonikos ID: fff7ed1d9227c009245541ec5254a5d8fcf2c73d
First added on: May 18, 2026